BBOT vs PVH · rev $7.5M vs P/E 24, rev $8.95B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus PVH Corp (PVH) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
PVH Corp (PVH) is a apparel manufacturing company listed on US.
Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Latest reported PVH revenue for 2026-02-01 was $8.95B. Net income was $25.3M. Revenue was up 3.4% from 2025-02-02 to 2026-02-01. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
BBOT currently screens at market cap $610.4M. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
Not investment advice. Open the BBOT and PVH stock pages for the full models.
Not investment advice.